Orbis Medicines
Orbis Medicines is a Healthcare & Life Sciences startup based in Switzerland, most recent round Series A, 1 tracked investor.
About Orbis Medicines
Orbis Medicines is a startup founded in 2020 based in Switzerland. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Orbis Medicines is a biotechnology company focused on the discovery and development of oral macrocycle drugs. It utilizes its AI-powered nGen platform to systematically explore macrocycle chemical space, aiming to create orally bioavailable alternatives to injectable biologic drugs for various therapeutic areas.
Explore Orbis Medicines's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.